Article
APRDX1 mutant allele causes a MMACHC secondary epimutation in cblC patients.
Nature communications - 4 Jan 2018
Guéant Jean-Louis, Chéry Céline, Oussalah Abderrahim, Nadaf Javad, Coelho David, Josse Thomas, Flayac Justine, Robert Aurélie, Koscinski Isabelle, Gastin Isabelle, Filhine-Tresarrieu Pierre, Pupavac Mihaela, Brebner Alison, Watkins David, Pastinen Tomi, Montpetit Alexandre, Hariri Fadi, Tregouët David, Raby Benjamin A, Chung Wendy K, Morange Pierre-Emmanuel, Froese D Sean, Baumgartner Matthias R, Benoist Jean-François, Ficicioglu Can, Marchand Virginie, Motorin Yuri, Bonnemains Chrystèle, Feillet François, Majewski Jacek, Rosenblatt David S
Abstract excerpt
To date, epimutations reported in man have been somatic and erased in germlines. Here, we identify a cause of the autosomal recessive cblC class of inborn errors of vitamin B12 metabolism that we name "epi-cblC". The subjects are compound heterozygotes for a genetic mutation and for a promoter epimutation, detected in blood, fibroblasts, and sperm, at the MMACHC locus; 5-azacytidine restores the expression of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
